These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 93347)

  • 1. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch.
    Dorner I; Moore JA; Collins JA; Sherman LA; Chaplin H
    Transfusion; 1975; 15(5):439-48. PubMed ID: 53916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of low molecular hydroxyethyl starch (HES) on the kidney -- a comparison with low molecular dextran].
    Yamasaki H
    Masui; 1975 Jun; 24(6):580-600. PubMed ID: 51106
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable studies of the behaviour of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl-starch (HES).
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):322-5. PubMed ID: 75005
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons.
    Tsuda Y; Hartmann A; Weiand J; Solymosi L
    J Neurol Sci; 1987 Dec; 82(1-3):171-80. PubMed ID: 2450177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation.
    Korttila K; Gröhn P; Gordin A; Sundberg S; Salo H; Nissinen E; Mattila MA
    J Clin Pharmacol; 1984 Jul; 24(7):273-82. PubMed ID: 6207208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function.
    Schiffer CA; Aisner J; Schmukler M; Whitaker CL; Wolff JH
    Transfusion; 1975; 15(5):473-5. PubMed ID: 53920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis.
    Lee JH; Cullis H; Leitman SF; Klein HG
    J Clin Apher; 1995; 10(4):198-202. PubMed ID: 8770713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethyl starch as a substitute for dextran 40 for thawing peripheral blood progenitor cell products.
    Zhu F; Heditke S; Kurtzberg J; Waters-Pick B; Hari P; Margolis DA; Keever-Taylor CA
    Cytotherapy; 2015 Dec; 17(12):1813-9. PubMed ID: 26454752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy.
    Mishler JM
    Transfusion; 1975; 15(5):449-60. PubMed ID: 53917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of hydroxyethyl starch on the flow properties of human erythrocyte suspensions.
    Corry WD; Jackson LJ; Seaman GV
    Biorheology; 1983; 20(5):705-17. PubMed ID: 6203575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function in donors undergoing intermittent-flow centrifugation plateletpheresis or leukapheresis.
    Maguire LC; Henriksen RA; Strauss RG; Goedken MM; Echternacht B; Koepke JA; Thompson JS
    Transfusion; 1980; 20(5):549-54. PubMed ID: 6158773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsubstituted hydrolyzed waxy maize as a potential agent for centrifugal leukacytapheresis.
    Studebaker JF; DeBroy JA
    Transfusion; 1984; 24(4):305-9. PubMed ID: 6205483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
    Mishler JM; Parry ES; Sutherland BA; Bushrod JR
    Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.